Joseph Jacobson, Co-Founder, Executive Chairman and CTO
Joseph Jacobson is Associate Professor at the Massachusetts Institute of Technology (MIT) where he is co-PI of the Center for Bits and Atoms and leads the Molecular Machine Group. His group at MIT is focused on pioneering the field of Avogadro Scale Engineering with applications in novel computing machines and synthetic biology. Jacobson received his PhD in Physics from MIT and was a post-doctoral fellow at Stanford in the area of Quantum Optics. He is the recipient of a 1999 Technology Review TR100 Award for Innovation, The 2000 Gutenberg Prize and a 2001 Discover Award. He has authored over 70 peer reviewed papers and conference proceedings in the fields of femotosecond lasers, quantum optics, molecular electronics, nano-chemistry and synthetic DNA. In the private sector Jacobson was co-founder of E Ink, Kovio and Gen9 and was a founding board member of One Laptop Per Child (OLPC) which is focused on developing a $100 laptop for kids.
George Church, Co-Founder
Professor of Genetics, Harvard Medical School, Director of the Center for Computational Genetics. 1984 Harvard PhD included the first direct genomic sequencing method, molecular multiplexing tags, which lead to automation & software used at Genome Therapeutics Corp. for the first commercial genome sequence -- pathogen, Helicobacter in 1994. This multiplex solid-phase sequencing evolved into polonies (1999), ABI-SOLiD (2005) & open-source Polonator.org (2007). Innovations in DNA reading, writing & allele replacement in cells lead to current research & commercialization in human genomics (Complete Genomics, PersonalGenomes.org, 23andme, Knome), synthetic biology (SynBERC, Joule, LS9) & new ethics/security strategies.
Drew Endy, Co-Founder
Drew Endy serves on the Stanford Bioengineering faculty and as board president of the BioBricks Foundation (BBF). He helped start the International Genetically Engineered Machines (iGEM) competition, the Registry of Standard Biological Parts, the BIOFAB, the SB#.0 conference series, and the US Synthetic Biology Engineering Research Center (SynBERC). He is a member of the US NAS Committee on Science, Technology, & Law (CSTL) and is nominated to the US National Science Advisory Board for Biosecurity (NSABB). His lab at Stanford works on scaling the composition and reliability of engineered biological systems. His passions are to make biology ever-easier to engineer and to ensure that the applications of biotechnology remain overwhelmingly constructive.